Atlas Trials

18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies

Clinical trial NCT04158245 · COMPLETED

Trial details

NCT number
NCT04158245
Sponsor
Tulane University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Castration-resistant Prostate Cancer
Start date
2020-01-30
Primary completion
2022-09-30
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.